Evidence map›Paper›PMID 25368398›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2014

Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.

Henry J Pollack, Simona C Kwon, Su H Wang, Laura C Wyatt, Chau Trinh-Shevrin, AAHBP Coalition

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Cluster-Randomized Trial to Increase Hepatitis B Testing among Koreans in Los Angeles.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Trial
  4. Article
  5. Review
  6. Applying Social Marketing Principles for Community-Based Cancer Screening Programs: Two Case Studies.Health education & behavior : the official publication of the Society for Public Health Education · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The changing epidemiology of liver diseases in the Asia-Pacific region.Nature reviews. Gastroenterology & hepatology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Henry J PollackDepartment of Pediatrics, New York University School of Medicine, New York, New York. henry.pollack@nyumc.org.
Simona C KwonDepartment of Population Health, New York University School of Medicine, New York, New York.
Su H WangSaint Barnabas Medical Center, Center for Asian Health, Livingston, New Jersey. Formerly at Charles B. Wang Community Health Center, New York, New York.
Laura C WyattDepartment of Population Health, New York University School of Medicine, New York, New York.
Chau Trinh-ShevrinDepartment of Population Health, New York University School of Medicine, New York, New York.
AAHBP Coalition
New York University · USSaint Barnabas Medical Center · US

Funding

Research Training and Education CoreP60MD000538 · NIMHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TRINH-SHEVRIN, CHAU · 2003 to 2017
$21.2M
Scaling Community-Clinical Linkage Models to Address Diabetes and Hypertension Disparities in the Southeastern U.S.U54MD000538 · NIMHD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TRINH-SHEVRIN, CHAU · 2017 to 2022
$11.3M
STRATEGIES TO REACH AND IMPLEMENT THE VISION OF HEALTHY EQUITY (STRIVE) PROJECTU58DP004685 · DP · ASIAN & PACIFIC ISLANDER AMER HLTH FORUM · PI KO, KATHY · 2012 to 2013
$4.3M
Racial and Ethnic Approaches to Community Health USU58DP001022 · DP · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI REY, MARIANO J · 2007 to 2011
$4.3M
NCCDPHP CDC HHS U58 DP001022NCCDPHP CDC HHS U58 DP004685NIMHD NIH HHS P60 MD000538NIMHD NIH HHS U54 MD000538
6 · The paper itself

Abstract

backgroundHepatitis B virus (HBV) infection, the predominant cause of hepatocellular carcinoma (HCC) worldwide, disproportionately affects Asian Americans. Limited data exist on the variability and characteristics of infection that determine disease progression risk within U.S. Asian ethnic subgroups.

methodsRetrospective analyses were conducted on a large, community-based HBV screening and treatment program in New York City (NYC). From 2004 to 2008, the program enrolled 7,272 Asian-born individuals. Determinants of HBV seroprevalence were calculated and risk factors for HCC progression were compared across Asian subgroups.

resultsAmong newly tested individuals, 13% were HBV positive. Seroprevalence varied significantly with age, gender, education, birthplace, and family history of infection. Chinese-born individuals, particularly from the Fujian province, had the highest seroprevalence (23.2% and 33.1%, respectively). Clinical and virologic characteristics placed HBV-infected individuals at significant risk for HCC. Significant differences in HCC risk existed among Asian subgroups in bivariate analysis, including age, gender, HBV viral load, and HBeAg status. Differences in HBV genotype and family history of HCC may further HCC risk among subgroups.

conclusionsAsian immigrants in NYC have a high prevalence of HBV infection and are at significant risk of disease progression and HCC. Although heterogeneity in HBV seroprevalence was found by Asian subgroups, HCC risk among infected individuals was primarily explained by age and gender differences. Country and province of birth, age, and gender may further explain seroprevalence differences. IMPACT: Findings provide estimates of HBV burden in Asian ethnic subgroups and identify high-risk groups to target for screening and treatment that can prevent HCC.

Indexed as

AdolescentAdultAgedAge FactorsAsiaAsianCarcinoma, HepatocellularEmigrants and ImmigrantsFemaleHepatitis B, ChronicHepatitis B e AntigensHepatitis B Surface AntigensHepatitis B virusHumansLiver NeoplasmsMaleHepatitis B e AntigensHepatitis B Surface Antigens

Identifiers

PMID25368398
PMCPMC4373070
OpenAlexW2136329603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.